Nicotine prevents HIVgp120-caused electrophysiological and motor disturbances in rats

Neuroscience Letters

Volumn 394, Issue 2, 2006, Pages 136-139

  González Lira, Británico ^a   Rueda Orozco, Pavel E ^a   Galicia, Oscar ^a   Montes Rodríguez, Corinne J ^a   Guzmán, Khalil ^a   Guevara Martínez, Marcela ^a   Elder, John H ^b   Prospéro García, Oscar ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cholinergic neurotransmission; Event related potentials; HIV associated dementia; N2; P3

Indexed keywords

GLYCOPROTEIN GP 120; NICOTINE;

ANIMAL EXPERIMENT; ARTICLE; AUDITORY STIMULATION; CHOLINERGIC TRANSMISSION; DRUG EFFECT; DRUG MECHANISM; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGY; EVENT RELATED POTENTIAL; HUMAN IMMUNODEFICIENCY VIRUS; MALE; MOTOR COORDINATION; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ANIMALS; DRUG INTERACTIONS; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, MOTOR; HIV ENVELOPE PROTEIN GP120; HUMANS; MALE; NICOTINE; NICOTINIC AGONISTS; PSYCHOMOTOR DISORDERS; RATS; RATS, WISTAR; ROTAROD PERFORMANCE TEST;

EID: 30344488181     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.10.021     Document Type: Article

References (30)

1. O. Barak, I. Goshen, T. Ben-Hur, J. Weidenfeld, AN. Taylor, and R. Yirmiya Involvement of brain cytokines in the neurobehavioral disturbances induced by HIV-1 glycoprotein120 Brain Res. 933 2002 98 108
2. G. Barbaro, A. Scozzafava, A. Mastrolorenzo, and C.T. Supuran Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome Curr. Pharm. Des. 11 2005 805 843
3. L. Bracci, S.K. Ballas, A. Sprefico, and P. Neri Molecular mimicry between the rabies virus glycoprotein and human immunodeficiency virus-1 gp120: cross-reacting antibodies induced by rabies vaccination Blood 90 1997 3623 3628
4. L. Bracci, L. Lozzi, M. Rustici, and P. Neri Binding of HIV-1 gp120 to the nicotinic receptor FEBS Lett. 311 1992 115 118
5. D.E. Brenneman, J. Hauser, C.Y. Spong, and T.M. Phillips Chemokines released from astroglia by vasoactive intestinal peptide. Mechanism of neuroprotection from HIV envelope protein toxicity Ann. N. Y. Acad. Sci. 921 2000 109 114
6. D.E. Brenneman, J. Hauser, C.Y. Spong, T.M. Phillips, C.B. Pert, and M. Ruff VIP and d-ala-peptide T-amide release chemokines which prevent HIV-1 gp120-induced neuronal death Brain Res. 838 1999 27 36
7. L.L. Chao, J.A. Lindgren, D.L. Flenniken, and M.W. Weiner ERP evidence of impaired central nervous system function in virally suppressed HIV patients on antiretroviral therapy Clin. Neurophys. 115 2004 1583 1591
8. S. Evers, A. Rahmann, S. Schwaag, A. Frese, D. Reichelt, and I.W. Husstedt Prevention of AIDS dementia by HAART does not depend on cerebrospinal fluid drug penetrance AIDS Res. Hum. Retroviruses 20 2004 483 491
9. S.A. Farr, W.A. Banks, K. Uezu, E.O. Freed, V.B. Kumar, and J.E. Morley Mechanisms of HIV type 1-induced cognitive impairment: evidence for hippocampal cholinergic involvement with overstimulation of the VIPergic system by the viral coat protein core AIDS Res. Hum. Retroviruses 18 2002 1189 1195
10. O. Galicia, M. Sánchez-Alavez, O. Diaz-Ruiz, F. Sanchez Narvaez, J.H. Elder, L. Navarro, and O. Prospero-Garcia HIV-derived protein gp120 suppresses P3 potential in rats: potential implications in HIV-associated dementia NeuroReport 11 2000 1351 1355
11. C. Gemma, and M.R. Opp Human immunodeficiency virus glycoproteins 160 and 41 alter sleep and brain temperature in rats J. Neuroimmunol. 97 1999 94 101
12. B. Giunta, J. Ehrhart, K. Townsend, N. Sun, M. Vendrame, D. Shytle, J. Tan, and F. Fernandez Galantamine and nicotine have synergistic effect on inhibition of microglial activation induced by HIV-1gp120 Brain Res. Bull. 64 2004 165 170
13. F. Gonzalez-Scarano, and J. Martín-García The neuropathogenesis of AIDS Nat. Rev. 5 2004 69 81
14. N.J. Haughey, and M.P. Mattson Calcium disregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120 J. Acquir. Immune Defic. Syndr. 31 Suppl. 2 2002 s55 s61
15. I.W. Husstedt, L. Frohne, S. Bockenholt, A. Frese, A. Rahmann, C. Heese, D. Reichelt, and S. Evers Impact of highly active antiretroviral therapy on cognitive processing in HIV infection: cross-sectional and longitudinal studies of event-related potentials AIDS Res. Hum. Retroviruses 18 2002 485 490
16. M.P. Mattson, N.J. Haughey, and A. Nath Cell death in HIV dementia Cell Death Differ. 2005 1 12
17. V. Mollace, H.S.L.M. Nottet, P. Clayette, M.C. Turco, C. Musculi, D. Salvemini, and C.F. Perno Oxidative stress and NeuroAIDS: triggers, modulators and novel antioxidants TINS 24 2001 411 416
18. C.J. Montes-Rodriguez, S. Alavez, J.H. Elder, R. Haro, J. Moran, and O. Prospero-Garcia Prolonged waking reduces human immunodeficiency virus glycoprotein 120- or tumor necrosis factor alpha-induced apoptosis in the cerebral cortex of rats Neurosci. Lett. 360 2004 133 136
19. T.R. Phillips, O. Prospéro-García, D.W. Wheeler, P.C. Wagaman, D.A. Lerner, H.S. Fox, L.R. Whalen, F.E. Bloom, J.H. Elder, and S.J. Henriksen Neurologic dysfunction caused by molecular clone of feline immunodeficiency virus, FIV-PPR J. NeuroVirol. 2 1996 388 396
20. J. Polich P300 clinical utility and control of variability J. Clin. Neurophysiol. 15 1998 14 33
21. J. Polich, and S. Basho P3a and P3b auditory ERPs in HIV patients receiving anti-viral medication Clin. Electroencephalogr. 33 2002 97 101
22. O. Prospéro-García, N. Herold, T. Phillips, J.H. Elder, F.E. Bloom, and S.J. Henriksen Sleep patterns are disturbed in cats infected with feline immunodeficiency virus Proc. Natl. Acad. Sci. U.S.A. 91 1994 12947 12951
23. O. Prospéro-García, S. Huitrón-Resendiz, S.C. Casalman, M. Sánchez-Alavez, O. Díaz-Ruiz, L. Navarro, D.L. Lerner, T.R. Phillips, J.H. Elder, and S.J. Henriksen Feline immunodeficiency virus envelope protein (FIVgp120) causes electrophysiological alterations in rats Brain Res. 836 1999 203 209
24. N.C. Sacktor, H. Bacellar, D.R. Hoover, T.E. Nance-Sproson, O.A. Selnes, E.N. Miller, G.J. Dal Pan, C. Kleeberger, A. Brown, A. Saah, and J.C. McArthur Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death J. NeuroVirol. 2 1996 404 410
25. N.C. Sacktor, R.L. Skolasky, R.H. Lyles, D. Esposito, O.A. Selnes, and J.C. McArthur Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors J. NeuroVirol. 6 2000 84 88
26. M. Sánchez-Alavez, J. Criado, M. Gomez-Chavarin, A. Jimenez-Anguiano, L. Navarro, O. Diaz-Ruiz, O. Galicia, F. Sanchez-Narvaez, E. Murillo-Rodriguez, S.J. Henriksen, J.H. Elder, and O. Prospero-Garcia HIV- and FIV-derived gp120 alter spatial memory, LTP, and sleep in rats Neurobiol. Dis. X 7 2005 384 394
27. J.L. Tartar, C.M. Sheehan, A.J. Nash, C. Starratt, A. Puga, and S. Widmayer ERPs differ from neurometric tests in assessing HIV-associated cognitive deficit NeuroReport 15 2004 1675 1678
28. Z. Wang, O. Pekarskaya, M. Bencheikh, W. Chao, H.A. Gelbard, A. Ghorpade, J.D. Rothstein, and D.J. Volsky Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120 Virology 312 2003 60 73
29. M.R. Weed, L.H. Gold, I. Polis, G.F. Koob, H.S. Fox, and M.A. Taffe Impaired performance on a rhesus monkey neuropsychological testing battery following simian immunodeficiency virus infection AIDS Res. Hum. Retroviruses. 20 2004 77 89
30. M.R. Weed, R.D. Hienz, J.V. Brady, R.J. Adams, J.L. Makowski, J.E. Clements, and M.C. Zink Central nervous system correlates of behavioral deficits following simian immunodeficiency virus infection J. Neurobiol. 9 2003 452 464